5-alkylvinyl-1,2,4-triazole nucleosides: Synthesis and biological evaluation

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Anticancer Drug Discovery

Background:

• Ribavirin analogues exhibit antiviral and anticancer properties through varied mechanisms.
• Structure-activity relationship (SAR) studies highlight the critical role of the 3(5)-substituent in 1,2,4-triazole nucleosides for biological activity.
• Previous research indicated that coplanar aromatic substituents linked by ethynyl bonds, and even trans-vinyl linkers, contribute to antiviral activity.

Purpose of the Study:

• To investigate the antitumor activity of novel ribavirin analogues featuring alkyl/aryl vinyl substituents at the 5th position of the 1,2,4-triazole ring.
• To evaluate the impact of these specific vinyl substituents on antiproliferative activity against various tumor cell lines.
• To further elucidate the structural requirements for anticancer activity in this class of compounds.

Main Methods:

• Synthesis of protected nucleoside analogues with 5-alkylvinyl substituents using the Horner-Wadsworth-Emmons reaction.
• Preparation of arylvinyl nucleosides following established synthetic procedures.
• Assessment of antiproliferative activity against multiple human tumor cell lines.

Main Results:

• The synthesized ribavirin analogues with alkyl/aryl vinyl substituents in the 5th position did not demonstrate significant antiproliferative activity.
• The study confirmed the importance of a coplanar aromatic motif within the 5-substituent for the manifestation of anticancer activity.
• Compounds lacking this specific structural feature were ineffective in inhibiting tumor cell growth.

Conclusions:

• The presence of a coplanar aromatic moiety connected to the 1,2,4-triazole ring is essential for the anticancer efficacy of these ribavirin analogues.
• Vinyl substituents, in the absence of this coplanar aromatic feature, do not confer significant antitumor activity.
• Further SAR studies are warranted to optimize the design of potent anticancer agents based on the ribavirin scaffold.